Literature DB >> 28306150

Biomarkers-A General Review.

Jeffrey K Aronson1, Robin E Ferner2,3.   

Abstract

A biomarker is a biological observation that substitutes for and ideally predicts a clinically relevant endpoint or intermediate outcome that is more difficult to observe. The use of clinical biomarkers is easier and less expensive than direct measurement of the final clinical endpoint, and biomarkers are usually measured over a shorter time span. They can be used in disease screening, diagnosis, characterization, and monitoring; as prognostic indicators; for developing individualized therapeutic interventions; for predicting and treating adverse drug reactions; for identifying cell types; and for pharmacodynamic and dose-response studies. To understand the value of a biomarker, it is necessary to know the pathophysiological relationship between the biomarker and the relevant clinical endpoint. Good biomarkers should be measurable with little or no variability, should have a sizeable signal to noise ratio, and should change promptly and reliably in response to changes in the condition or its therapy. © 2017 by John Wiley & Sons, Inc.
Copyright © 2017 John Wiley & Sons, Inc.

Keywords:  adverse drug reactions; biomarkers; diagnosis; drug development; drug discovery; monitoring drug therapy; screening; surrogate endpoints; surrogate markers

Mesh:

Substances:

Year:  2017        PMID: 28306150     DOI: 10.1002/cpph.19

Source DB:  PubMed          Journal:  Curr Protoc Pharmacol        ISSN: 1934-8282


  27 in total

Review 1.  Uncovering epigenetic landscape: a new path for biomarkers identification and drug development.

Authors:  Daiane Teixeira de Oliveira; Renata Guerra-Sá
Journal:  Mol Biol Rep       Date:  2020-10-21       Impact factor: 2.316

2.  Machine learning reveals serum sphingolipids as cholesterol-independent biomarkers of coronary artery disease.

Authors:  Annelise M Poss; J Alan Maschek; James E Cox; Benedikt J Hauner; Paul N Hopkins; Steven C Hunt; William L Holland; Scott A Summers; Mary C Playdon
Journal:  J Clin Invest       Date:  2020-03-02       Impact factor: 14.808

3.  Dielectric property measurement of human sweat using attenuated total reflection terahertz time domain spectroscopy.

Authors:  Kazuma Hashimoto; Paul Ben Ishai; Erik Bründermann; Saroj R Tripathi
Journal:  Biomed Opt Express       Date:  2022-08-04       Impact factor: 3.562

Review 4.  Central Nervous System Pericytes Contribute to Health and Disease.

Authors:  Francesco Girolamo; Mariella Errede; Antonella Bizzoca; Daniela Virgintino; Domenico Ribatti
Journal:  Cells       Date:  2022-05-20       Impact factor: 7.666

5.  Using Brain Oscillations and Corticospinal Excitability to Understand and Predict Post-Stroke Motor Function.

Authors:  Aurore Thibaut; Marcel Simis; Linamara Rizzo Battistella; Chiara Fanciullacci; Federica Bertolucci; Rodrigo Huerta-Gutierrez; Carmelo Chisari; Felipe Fregni
Journal:  Front Neurol       Date:  2017-05-10       Impact factor: 4.003

Review 6.  Resting State Functional Connectivity Biomarkers of Treatment Response in Mood Disorders: A Review.

Authors:  Joseph J Taylor; Hatice Guncu Kurt; Amit Anand
Journal:  Front Psychiatry       Date:  2021-03-26       Impact factor: 4.157

7.  Variations in biomarkers of dyslipidemia and dysbiosis during the menstrual cycle: a pilot study in healthy volunteers.

Authors:  Helena Bergström; Lena Ekström; Anna Warnqvist; Peter Bergman; Linda Björkhem-Bergman
Journal:  BMC Womens Health       Date:  2021-04-20       Impact factor: 2.809

8.  D-Dimer as Biomarker for Early Prediction of Clinical Outcomes in Patients With Severe Invasive Infections Due to Streptococcus Pneumoniae and Neisseria Meningitidis.

Authors:  Simone Meini; Emanuela Sozio; Giacomo Bertolino; Francesco Sbrana; Andrea Ripoli; Carlo Pallotto; Bruno Viaggi; Roberto Andreini; Vittorio Attanasio; Carolina Rescigno; Luigi Atripaldi; Silvia Leonardi; Mariano Bernardo; Carlo Tascini
Journal:  Front Med (Lausanne)       Date:  2021-04-15

Review 9.  Searching for Peripheral Biomarkers in Neurodegenerative Diseases: The Tryptophan-Kynurenine Metabolic Pathway.

Authors:  Nóra Török; Masaru Tanaka; László Vécsei
Journal:  Int J Mol Sci       Date:  2020-12-08       Impact factor: 5.923

10.  The Gasdermin E Gene Has Potential as a Pan-Cancer Biomarker, While Discriminating between Different Tumor Types.

Authors:  Joe Ibrahim; Ken Op de Beeck; Erik Fransen; Marc Peeters; Guy Van Camp
Journal:  Cancers (Basel)       Date:  2019-11-18       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.